{"id":1784,"date":"2026-04-09T12:00:21","date_gmt":"2026-04-09T12:00:21","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/04\/09\/dosing-begins-in-trial-testing-treatment-for-ms-obesity\/"},"modified":"2026-04-09T12:00:21","modified_gmt":"2026-04-09T12:00:21","slug":"dosing-begins-in-trial-testing-treatment-for-ms-obesity","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/04\/09\/dosing-begins-in-trial-testing-treatment-for-ms-obesity\/","title":{"rendered":"Dosing begins in trial testing treatment for MS, obesity"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/04\/09\/dosing-begins-trial-testing-treatment-ms-obesity\/\" title=\"Dosing begins in trial testing treatment for MS, obesity\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"533\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/04\/iStock-2211671827-800x533.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A patient has blood drawn.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"161086\" \/><\/a><\/p>\n<p>The first participant has been dosed in a Phase 1 clinical trial testing TNV262, an experimental therapy that Tenvie Therapeutics is developing as a potential treatment for multiple sclerosis (MS) and other conditions including obesity and cardiovascular disease. The Phase 1a\/1b study will test single and multiple doses of TNV262 in healthy volunteers and people [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/04\/09\/dosing-begins-trial-testing-treatment-ms-obesity\/\">Dosing begins in trial testing treatment for MS, obesity<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/04\/09\/dosing-begins-trial-testing-treatment-ms-obesity\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The first participant has been dosed in a Phase 1 clinical trial testing TNV262, an experimental therapy that Tenvie Therapeutics is developing as a potential treatment for multiple sclerosis (MS) and other conditions including obesity and cardiovascular disease. The Phase 1a\/1b study will test single and multiple doses of TNV262 in healthy volunteers and people&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1785,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1784","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1784"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1784\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1785"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}